跳至主要内容
临床试验/NCT03642171
NCT03642171已完成不适用

A Post Market Surveillance Study of the Performance and Safety of UT 380® Contraceptive Intra Uterine Device in Nulliparous, Uniparous and Multiparous Women

Quanta Medical1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2018年7月26日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
200
试验地点
1
主要终点
Unintended pregnancy rate

研究概览

简要总结

The study is a long term Post Market Surveillance Study involving women who will received UT 380® device as a contraceptive method.

详细描述

Prospective data on contraceptive performance of the UT380® from a large number of women are not yet available. Here we describe a long term Post Market Surveillance Study involving women who will received UT 380® device as a contraceptive method. Reports of case series usually contain detailed information about the individual patients. This includes demographic information (e.g. age and gender) and information on diagnosis, treatment, response to treatment, follow-up after treatment and patients experience of the treatment. In addition, it also include the health care staff's experience of the use of the UT 380. The result of this study will be used for different purposes e.g. marketing activities such as posters, folders, or targeted journals and/or conferences.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Woman > 18 years old
  • nulliparous, uniparous and multiparous
  • not currently using a contraceptive method or are willing to switch to a new reversible contraceptive
  • with an indication of implantation of a UT380® IUD
  • agreeing to participate in the study

排除标准

  • Patient with risk of post implantation bleeding or high level of bleeding during menstruation period
  • Patient with a risk of infection
  • Patient that meet any of the absolute contraindication of UT 380®
  • Any other elements that the investigator may think relevant and cannot allow the use of UT380®

结局指标

主要结局

Unintended pregnancy rate

时间窗: 5 years

Unintended pregnancy rate

Device expulsion rate

时间窗: 5 years

Device expulsion rate

Discontinuation rate

时间窗: 5 years

Discontinuation rate

次要结局

  • Removal rate of the UT380® due to excessive bleeding(5 years)
  • Extra uterine pregnancy rate(5 years)
  • Removal rate of the UT380® due to pelvic inflammatory diseases(5 years)
  • Assessment of physicians satisfaction regarding the use of the UT380 using 5 points likert scale (1: not at all satisfied 5: very satisfied)(5 years)
  • Removal rate of the UT380® due to other disease relevant in the contexte of the trial(5 years)
  • Safety data such as any issue occurring immediately after the implantation of the device(5 years)
  • Safety data such as any issue during the device removal (such as pain, breaking device, excessive pulling force…)(5 years)
  • Removal rate of the UT380® due to desired pregnancy(5 years)
  • Removal rate of the UT380® due to any other personal reason(5 years)
  • Assessment of patients satisfaction regarding the use of the UT 380® using 5 points likert scale (1: not at all satisfied 5: very satisfied)(5 years)
  • Removal rate of the UT380® due to pain(5 years)
  • Removal rate of the UT380® due to investigator decision(5 years)
  • Safety data such as uterin perforation(5 years)
  • Safety data such as any issue occurring between two visits: Abdominopelvic or uterine pain outside the menstrual cycle, bleeding,(5 years)

研究者

发起方
Quanta Medical
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验